Indirect activation of NFκB pathway due to aberrant oncogenic signaling is a common phenomenon in many types of cancer, which increases the capacity for tumor cells to evade apoptosis and gain a survival advantage over normal, untransformed cells. Here, NFKB1 is linked to cancer.